期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
XBP1 splicing contributes to endoplasmic reticulum stress-induced human islet amyloid polypeptide up-regulation
1
作者 Yun Zhang Susan Lin +5 位作者 Jing Yao Wantong Cai Huaqiu Chen ailikemu aierken Zhe Wang Weihong Song 《Genes & Diseases》 SCIE CSCD 2024年第5期350-359,共10页
As a pathological hallmark of type 2 diabetes mellitus(T2DM),islet amyloid is formed by the aggregation of islet amyloid polypeptide(IAPP).Endoplasmic reticulum(ER)stress interacts with IAPP aggregates and has been im... As a pathological hallmark of type 2 diabetes mellitus(T2DM),islet amyloid is formed by the aggregation of islet amyloid polypeptide(IAPP).Endoplasmic reticulum(ER)stress interacts with IAPP aggregates and has been implicated in the pathogenesis of T2DM.To examine the role of ER stress in T2DM,we cloned the hIAPP promoter and analyzed its promoter activity in human b-cells.We found that ER stress significantly enhanced hIAPP promoter activity and expression in human b-cells via triggering X-box binding protein 1(XBP1)splicing.We identified a binding site of XBP1 in the hIAPP promoter.Disruption of this binding site by substitution or deletion mutagenesis significantly diminished the effects of ER stress on hIAPP promoter activity.Blockade of XBP splicing by MKC3946 treatment inhibited ER stress-induced hIAPP up-regulation and improved human b-cell survival and function.Our study uncovers a link between ER stress and IAPP at the transcriptional level and may provide novel insights into the role of ER stress in IAPP cytotoxicity and the pathogenesis of T2DM. 展开更多
关键词 b-cell function Endoplasmic reticulum stress Islet amyloid polypeptide Type 2 diabetes mellitus XBP1
原文传递
阿尔茨海默症生物标志物在脑脊液和血液中的研究 被引量:1
2
作者 艾力克木·艾尔肯 全贞贞 庆宏 《生命科学》 CSCD 北大核心 2021年第8期939-945,共7页
阿尔茨海默症(Alzheimer’s disease,AD)是一种常见的神经退行性疾病。因为疾病本身很难被治愈,因此早期预测诊断对AD的防治尤为重要。目前,痴呆前期AD的主要诊断方法是脑脊液生物标志物的检测和正电子发射式计算机断层扫描(PET),但是... 阿尔茨海默症(Alzheimer’s disease,AD)是一种常见的神经退行性疾病。因为疾病本身很难被治愈,因此早期预测诊断对AD的防治尤为重要。目前,痴呆前期AD的主要诊断方法是脑脊液生物标志物的检测和正电子发射式计算机断层扫描(PET),但是这两种诊断方法侵入性强,价格昂贵,不容易普及。而对血液中的AD相关标志物进行检测,可以使AD的诊断更为普及且更为方便。该文总结了目前AD主要的几种生物标志物,概述了它们在AD患者和正常个体脑脊液和血液中的变化,最后也讨论和分析了未来AD生物标志物在血液检测中可能遇到的挑战。 展开更多
关键词 阿尔茨海默症 生物标志物 脑脊液 血液检测
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部